Lumida
/HRTX
⌘K
Heron Therapeutics Inc

Heron Therapeutics Inc

HRTX
$0.32USD-2.11%-0.01 today

MARKET CAP

59.9M

P/E (TTM)

FWD P/E

DAY RANGE

$0 – $0

52W RANGE

$0
$2

AI Summary

Stalk
Sell NowMedium

HRTX remains in a Stage 4 decline with a clear sequence of lower highs and lower lows. Price trades below the 9, 21, and 50 EMAs, which continue to slope down and act as resistance. Although a Post-Capitulation pattern indicates selling exhaustion at the recent low, the absence of any repair above intermediate EMAs confirms medium-term bearish control. The tradable side is bearish, and execution should involve selling now into failed retests of the short-term EMAs. Key risks include a decisive reclaim of the 9/21 EMAs and a sustained break above the 50 SMA that could invalidate the downtrend.

  • APONVIE sales grew 74% YoY, driving surgical NK-1 segment momentum
  • Tax Benefit Preservation Plan extended to July 2029 enhances cash runway
  • Q2 net loss of $5.5M and $0.03 EPS missed consensus
Full analysis →
Insider Trades12 trades
DateSideTickerInsiderRoleSharesPriceMkt Cap52W High52W LowValue% ChgRuleAI View
Aug 6, 2026SellHRTXMark Earl HensleyChief Operating Officer8,888$0.50$59.9M-79.97%+6.05%$4.4K-1.70%Sell Now
Jul 30, 2026SellHRTXWilliam P ForbesEVP, Chief Development Officer6,674$0.50$59.9M-79.97%+6.05%$3.3K-0.88%Sell Now
Jul 30, 2026SellHRTXIra DuarteEVP, Chief Financial Officer7,176$0.50$59.9M-79.97%+6.05%$3.6K-0.83%Sell Now
Jul 19, 2026SellHRTXIra DuarteEVP, Chief Financial Officer1,101$0.47$59.9M-79.97%+6.05%$517.47-0.38%Sell Now
Jul 19, 2026SellHRTXWilliam P ForbesEVP, Chief Development Officer1,101$0.47$59.9M-79.97%+6.05%$517.47-0.44%Sell Now
Jun 16, 2026SellHRTXIra DuarteEVP, Chief Financial Officer3,555$0.38$59.9M-79.97%+6.05%$1.4K-1.28%Sell Now
Apr 19, 2024SellHRTXIra DuarteEVP, Chief Financial Officer1,122$2.64$59.9M-79.97%+6.05%$3.0K-0.76%Sell Now
Jan 13, 2024SellHRTXLisa PerazaVP, Chief Accounting Officer756$2.15$59.9M-79.97%+6.05%$1.6K-1.16%Sell Now
Nov 17, 2023BuyHRTXWilliam P ForbesEVP, Chief Development Officer25,000$1.09$59.9M-79.97%+6.05%$27.3K+46.30%Sell Now
Nov 16, 2023BuyHRTXWilliam P ForbesEVP, Chief Development Officer50,000$0.94$59.9M-79.97%+6.05%$47.0K+1250.00%Sell Now
Nov 16, 2023BuyHRTXIra DuarteEVP, Chief Financial Officer85,000$0.89$59.9M-79.97%+6.05%$75.6KSell Now
Nov 16, 2023BuyHRTXCraig A CollardChief Executive Officer150,000$0.92$59.9M-79.97%+6.05%$138.0K+411.00%Sell Now